SMTL ID : 2hv5.1

Human Aldose Reductase complexed with inhibitor zopolrestat after three days soaking (3days_soaked_3)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.59 Å

Oligo State

monomer

Ligands

1 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 33 residues within 4Å: Chain A: G.19, T.20, W.21, K.22, D.44, Y.49, K.78, H.111, W.112, S.160, N.161, Q.184, Y.210, S.211, P.212, L.213, G.214, S.215, P.216, D.217, L.229, A.246, I.261, P.262, K.263, S.264, V.265, T.266, R.269, E.272, N.273, C.299 Ligands: ZST.2 32 PLIP interactions: 32 interactions with chain A Hydrophobic interactions: A:W.21 Hydrogen bonds: A:T.20, A:W.21, A:D.44, A:S.160, A:N.161, A:Q.184, A:S.211, A:L.213, A:G.214, A:S.215, A:S.215, A:D.217, A:D.217, A:K.263, A:S.264, A:V.265, A:T.266, A:T.266, A:E.272, A:N.273 Water bridges: A:D.217, A:D.217, A:R.269, A:R.269, A:R.269, A:R.269 Salt bridges: A:K.22, A:K.263, A:R.269 pi-Stacking: A:Y.210 pi-Cation interactions: A:R.269

1 x ZST: 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID(Non-covalent)

ZST.2: 16 residues within 4Å: Chain A: W.21, V.48, Y.49, H.111, W.112, T.114, F.116, F.123, W.220, C.299, A.300, L.301, C.304, Y.310, P.311 Ligands: NAP.1 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:W.21, A:W.21, A:W.112, A:F.116, A:F.123 Hydrogen bonds: A:Y.49, A:Y.49 Salt bridges: A:H.111 pi-Stacking: A:W.112, A:W.112, A:W.112 Halogen bonds: A:C.304

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Steuber, H. et al., Expect the unexpected or caveat for drug designers: multiple structure determinations using aldose reductase crystals treated under varying soaking and co-crystallisation conditions. J.Mol.Biol. (2006)

Release Date

2006-10-03

Peptides

Aldose reductase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Aldose reductase

Related Entries With Identical Sequence